KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $71.0 million.

  • Gilead Sciences' Gains from Investment Securities rose 68888.89% to $71.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$174.0 million, marking a year-over-year decrease of 92352.94%. This contributed to the annual value of $492.0 million for FY2024, which is 15956.42% up from last year.
  • Per Gilead Sciences' latest filing, its Gains from Investment Securities stood at $71.0 million for Q3 2025, which was up 68888.89% from $142.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Gains from Investment Securities ranged from a high of $410.0 million in Q1 2024 and a low of -$470.0 million during Q4 2023
  • In the last 5 years, Gilead Sciences' Gains from Investment Securities had a median value of -$142.0 million in 2021 and averaged -$83.6 million.
  • Per our database at Business Quant, Gilead Sciences' Gains from Investment Securities tumbled by 42280.7% in 2022 and then skyrocketed by 68888.89% in 2025.
  • Over the past 5 years, Gilead Sciences' Gains from Investment Securities (Quarter) stood at $57.0 million in 2021, then crashed by 422.81% to -$184.0 million in 2022, then plummeted by 155.43% to -$470.0 million in 2023, then soared by 108.3% to $39.0 million in 2024, then skyrocketed by 82.05% to $71.0 million in 2025.
  • Its Gains from Investment Securities was $71.0 million in Q3 2025, compared to $142.0 million in Q2 2025 and -$426.0 million in Q1 2025.